AstraZeneca PLC (AZN) Stock Up 6.1% but GF Value Says Overvalued -- GF Score: 76/100

AstraZeneca (AZN) shares jumped 6.1% to $195.15 on July 2, 2026. The article provides no underlying catalyst (e.g., earnings, guidance, or deal details), so the move appears to reflect improving investor sentiment and momentum rather than a specific new fundamental development.

Analysis

AstraZeneca (AZN) shares jumped 6.1% to $195.15 on July 2, 2026. The article provides no underlying catalyst (e.g., earnings, guidance, or deal details), so the move appears to reflect improving investor sentiment and momentum rather than a specific new fundamental development.